New Delhi: Market regulator Securities and Exchange Board of India (SEBI) today asked mutual fund (MF) houses to give investors the option to cash out when the fund administration fee goes up as a result of new rules, reports PTI.
Currently, MFs charge investors a flat fee of 2.25% on the average of daily or weekly net assets.
SEBI had, in a 29th July notification, said that the total expense, including management fees, charged from investors in a fund-of-fund scheme should not exceed 0.75% of either the daily or weekly average net assets-which would benefit the investor.
Alternatively, it said that fund houses could cap the management expenses at 0.75% and fix their own fee for administrative expenses, provided the total charge does not exceed 2.5% of the daily or weekly average net assets.
In the case of an index fund scheme or exchange-traded fund, SEBI wanted that the total fee charged from an investor, including the investment and advisory expenses, does not exceed 1.5% of the weekly average net assets.
"Fund-of-fund schemes existing as on 29th July shall with the approval of trustees adopt either of the total expense structures laid out... and change the total expense structure after giving the unit holders an option to exit," SEBI said in a circular.
Fund-of-fund schemes are those where a mutual fund invests in a scheme of another MF.
SEBI had issued revised regulations to the fund houses for prescribing changes in the calculation of total expenses charged by them from investors. The expense fee charged by MF houses from investors includes redemption expenses, investment management and advisory fees, among others.
The fund houses have come under SEBI'S scanner for allegedly giving their agents and distributors lavish incentives like cash payouts and foreign junkets in return for higher sales. They choose to include this expenditure under the head of management expense, thereby charging investors for the same.
Instances of distributors of various fund houses being showered with cash incentives and trips to exotic locations in India and abroad have come to light since the practice of charging an entry-load from investors was scrapped last year.
Entry load is the commission that an investor has to pay while purchasing units of a mutual fund.
Orchid Chemicals and Pharmaceuticals Ltd has received approval from the US Food and Drug Administration (USFDA) to sell levetiracetam tablets, 1,000 mg in that country. Levetiracetam is used in the treatment of epilepsy.
On Monday, Orchid Chemicals shares ended 0.8% up to Rs190 on the Bombay Stock Exchange, while the Sensex closed 0.7% up at 18,278 points.
Auto parts and equipment manufacturer EL Forge Ltd said its net loss narrowed to Rs2.7 crore for the 30 June 2010 quarter as compared to Rs4.9 crore a year ago due to robust revenues.
During the June 2010 quarter, the Chennai-based company's total revenues increased to Rs17.8 crore from Rs9.5 crore in June 2009 quarter, EL Forge said in a regulatory filing.
On Monday, EL Forge shares increased 3% to Rs27 on the Bombay Stock Exchange, while the Sensex closed 0.7% up at 18,278 points.